Merus: Funding, Investors & Team (Sep 2026)
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our most advanced research programs utilize the Biclonics® format, which have the unique ability to attack tumors in multiple ways. These Biclonics® can activate the immune system to eliminate tumor cells and directly hinder the growth and survival processes of these cells. Choosing to work at Merus means embarking on a career that offers personal and professional growth, as well as success for the company. By joining our team, you will contribute to the advancement of bispecific antibody therapies (Biclonics®) in the fight against cancer. Merus is headquartered in The Netherlands and has offices in the US, collaborating with partners around the globe. We have been listed on NASDAQ since 2016 and have several promising drugs in clinical trials spanning a decade. For more information, please visit our website at www.merus.nl. To ensure a positive community environment, we encourage you to review our Community Guidelines by visiting this link: https://merus.nl/community-guidelines/
Merus has raised $850M across 3 funding rounds on record, the most recent an undisclosed round of $300M announced in Jun 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Merus Company Profile and Key Stats
Latest funding round on record: Jun 2025.
Merus Funding Rounds
Merus raised $150M in an undisclosed round announced in Aug 2023.
9 months later, an undisclosed round of $400M was announced in May 2024.
1.1 years later, an undisclosed round of $300M was announced in Jun 2025.
Merus Founders and Leadership Team
Contact details for the Merus team: 1 of 1 has an email address on file.
Start 14-day free trial →Merus Funding Compared to Other Biotechnology Startups
Merus' latest round of $300M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Merus in Biotechnology and Utrecht
Companies Similar to Merus
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…
Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…
We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…
QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.
Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…
QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…
Citryll is a private pharmaceutical company that develops pharmaceutical drugs used to treat autoimmune and…
Merus Funding FAQs
What does Merus do?
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our most advanced research programs utilize the Biclonics® format, which have the unique ability to attack tumors in multiple ways. These Biclonics® can activate the immune system to eliminate tumor cells and directly hinder the growth and survival processes of these cells. Choosing to work at Merus means embarking on a career that offers personal and professional growth, as well as success for the company. By joining our team, you will contribute to the advancement of bispecific antibody therapies (Biclonics®) in the fight against cancer. Merus is headquartered in The Netherlands and has offices in the US, collaborating with partners around the globe. We have been listed on NASDAQ since 2016 and have several promising drugs in clinical trials spanning a decade. For more information, please visit our website at www.merus.nl. To ensure a positive community environment, we encourage you to review our Community Guidelines by visiting this link: https://merus.nl/community-guidelines/
How much funding has Merus raised?
Merus has raised $850M across 3 rounds on record. The most recent is an undisclosed round of $300M announced in Jun 2025.
When did Merus last raise funding?
Merus' most recent funding round on record is an undisclosed round of $300M, announced in Jun 2025.
Who founded Merus?
FundedIQ lists Ton Logtenberg (Founder) at Merus.
Where is Merus headquartered?
Merus is based in Utrecht, Netherlands.
How many employees does Merus have?
Merus is in the 101-250 employee band.
How does Merus' funding compare to other Biotechnology startups?
Merus' latest round of $300M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Merus Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Merus is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.